Aetna (AET) Holdings Lifted by CQS Cayman LP

CQS Cayman LP boosted its holdings in shares of Aetna (NYSE:AET) by 3,583.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 110,500 shares of the company’s stock after acquiring an additional 107,500 shares during the period. CQS Cayman LP’s holdings in Aetna were worth $18,675,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of AET. Focused Wealth Management Inc lifted its holdings in Aetna by 84.5% during the fourth quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock worth $118,000 after acquiring an additional 300 shares in the last quarter. Cerebellum GP LLC bought a new position in Aetna during the fourth quarter worth about $125,000. Centaurus Financial Inc. acquired a new stake in shares of Aetna in the 1st quarter valued at about $128,000. James Hambro & Partners acquired a new stake in shares of Aetna in the 4th quarter valued at about $158,000. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Aetna in the 4th quarter valued at about $180,000. Hedge funds and other institutional investors own 84.19% of the company’s stock.

NYSE:AET opened at $177.12 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $58.01 billion, a P/E ratio of 17.20, a P/E/G ratio of 1.50 and a beta of 0.64. Aetna has a 52-week low of $142.66 and a 52-week high of $194.40.

Aetna (NYSE:AET) last released its earnings results on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.97 by $0.22. The business had revenue of $15.34 billion for the quarter, compared to the consensus estimate of $15.32 billion. Aetna had a return on equity of 21.42% and a net margin of 5.76%. Aetna’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.71 earnings per share. analysts anticipate that Aetna will post 11.06 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 1st. Investors of record on Wednesday, July 25th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Tuesday, July 24th. Aetna’s dividend payout ratio is currently 20.28%.

Several analysts have issued reports on the company. Credit Suisse Group dropped their price target on Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a research note on Monday, May 14th. Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Cantor Fitzgerald raised Aetna from a “neutral” rating to an “overweight” rating in a research note on Tuesday, May 1st. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Jefferies Group reissued a “hold” rating and issued a $205.00 price target on shares of Aetna in a research note on Wednesday, January 31st. Eight equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $196.36.

Aetna Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply